TF and cancer: A total of 47 cfDNA samples from 15 patients were analyzed using genome-wide DELFI-TF analyses as well as the validated elio plasma complete 2.2 Mb panel of common cancer driver genes with deep targeted sequencing (~25,000x coverage).